EHRA Premium Access

The role of digoxin in atrial fibrillation.


About the speaker

Professor Paulus Kirchhof

University Heart & Vascular Center Hamburg, Hamburg (Germany)
43 presentations
0 follower

4 more presentations in this session

AV nodal blocking therapy in AF: when, how and for whom?

Speaker: Associate Professor S. Boveda (Toulouse, FR)


The role of a calcium channel blocker in atrial fibrillation.

Speaker: Doctor R. Tieleman (Groningen, NL)


Ablate and pace: the preferred therapy now?

Speaker: Professor P. Vardas (Heraklion, GR)


Is there still room for drugs to control AV nodal conduction in AF? - discussion.


Access the full session

Is there still room for drugs to control atrioventricular nodal conduction in atrial fibrillation (AF)?

Speakers: Professor P. Kirchhof, Associate Professor S. Boveda, Doctor R. Tieleman, Professor P. Vardas

About the event


EHRA 2022

3 April - 5 April 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk